13th World Congress on
Neurology and Therapeutics

Welcome Message

Esteemed colleagues, researchers, clinicians, and distinguished guests,

Our theme, "From Research to Recovery: Transforming Neurology Through Innovation," captures the essence of our mission—to bridge groundbreaking research with practical therapies that improve lives worldwide. Over the next two days, we will explore the latest discoveries, cutting-edge treatment approaches, and collaborative strategies shaping the future of neurology.

Thank you for joining us on this impactful journey. Let’s make this event memorable, insightful, and transformative.

This message is crafted to be unique, warm, professional, and motivating, while reflecting the conference theme and setting a positive tone for the event.

In pursuit of excellence,
Ellie Rebecca
Program Manager | Neurology 2025
WhatsApp: +44 7389 644903

About

Neurology is evolving rapidly — are you ready to be part of the transformation?

Prague, Czech Republic, will host the 13th World Congress on Neurology and Therapeutics on May 14–15, 2026, bringing together leaders in neurology, neurosurgery, neuroscience, and healthcare innovation to shape the future of brain health.

Theme 2026: From Research to Recovery: Transforming Neurology Through Innovation

This congress will highlight:

• Precision neurotherapies & advanced diagnostics
• AI-driven neurotech & digital healthcare
• Breakthroughs in neurorehab & brain imaging
• Emerging solutions for neurodegenerative diseases

Expect engaging sessions through workshops, live demos, clinical case discussions, and expert panels that connect science with practical application.

Why Attend?

• Stay Updated: Discover the newest trends in diagnostics, therapeutics, and neurological care.
• Connect Globally: Meet top neurologists, researchers, and innovators.
• Showcase Research: Present your work and gain international recognition.
• Get Inspired: Explore fresh ideas that spark new clinical and research directions.

Who Can Benefit?

• Researchers & Academics
• Medical Associations & Societies
• Clinicians & Healthcare Professionals

Neurology 2026 isn’t just a conference — it’s a platform to learn, collaborate, and shape the future of brain health.

Join us in Prague and be part of breakthroughs that matter.

Where minds connect, innovation grows.

Sessions

Session 1: Neurology

Neurology is the medical specialty devoted to understanding and treating disorders of the nervous system, including the brain, spinal cord, and peripheral nerves. This Session highlights advances in diagnosis, neuroimaging, and innovative therapies, emphasizing translational research that connects lab discoveries to clinical care. Emerging treatments, neuroprotective strategies, and preventive neurology are also key focus areas.

Sub-Tracks:

• Neurodegenerative Diseases

• Neurodiagnostic Techniques

• Neurorehabilitation

• Nervous System Infections

• Emerging Neurological Therapies

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 2: Clinical Neurology

Clinical Neurology focuses on applying neurological science directly to patient care, improving diagnosis, management, and treatment of nervous system disorders. This Session emphasizes clinical research, patient-centered care, and innovative diagnostic techniques. Topics include neurological assessment, neuroimaging advances, and evolving therapies for chronic and acute neurological conditions, supporting improved outcomes and quality of life for patients.

Sub-Tracks:

• Neurodiagnostic Methods

• Neurological Examination Protocols

• Chronic Neurological Disorder Management

• Acute Neurology Interventions

• Clinical Trials in Neurology

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 3: Neuroscience

Neuroscience explores the structure, function, development, and pathology of the nervous system. This Session covers molecular, cellular, and systems-level neuroscience research, highlighting discoveries in neuroplasticity, neurogenesis, and synaptic function. It bridges basic research with clinical applications, fostering innovations in understanding brain function, cognitive processes, and neurological disorders, paving the way for new therapies and interventions.

Sub-Tracks:

• Molecular and Cellular Neuroscience

• Cognitive Neuroscience

• Neuroplasticity and Neurogenesis

• Neuroimaging and Brain Mapping

• Translational Neuroscience

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 4: Neuroplasticity

Neuroplasticity explores the nervous system’s ability to adapt and reorganize itself following injury, disease, or environmental changes. This Session emphasizes rehabilitation strategies, neural regeneration, and the mechanisms driving synaptic plasticity. Emerging research on neuroplasticity informs therapies for stroke, traumatic brain injury, and neurodegenerative disorders, offering hope for restoring function and enhancing recovery through innovative interventions and targeted treatments.

Sub-Tracks:

• Synaptic Plasticity Mechanisms

• Neural Regeneration Strategies

• Stroke and Injury Rehabilitation

• Neuroplasticity in Neurodegenerative Disorders

• Cognitive and Motor Recovery

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 5: Neurological Nursing

Neurological Nursing focuses on specialized care for patients with nervous system disorders. This Session emphasizes assessment, patient management, nursing interventions, and education for conditions such as stroke, epilepsy, and neurodegenerative diseases. Innovations in nursing practices, multidisciplinary care, and the integration of technology in monitoring and patient support are explored, highlighting the pivotal role of nurses in promoting recovery and improving quality of life.

Sub-Tracks:

• Neurocritical Care Nursing

• Stroke Nursing and Rehabilitation

• Epilepsy Nursing

• Patient Monitoring Technologies

• Nursing Education and Training

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 6: Neuromuscular Disorders

Neuromuscular disorders involve diseases that affect muscles, nerves, and neuromuscular junctions, leading to weakness, fatigue, or paralysis. This Sessionhighlights advances in diagnosis, molecular genetics, and treatment strategies, including gene therapy and novel pharmacological interventions. Emphasis is placed on early detection, personalized therapies, and rehabilitation approaches to improve patient mobility, quality of life, and long-term outcomes.

Sub-tracks:

• Muscular Dystrophies

• Motor Neuron Diseases

• Peripheral Neuropathies

• Neuromuscular Junction Disorders

• Rehabilitation Strategies

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 7: Nervous System Disorders

Nervous system disorders encompass a wide range of conditions affecting the brain, spinal cord, and peripheral nerves. This Sessionexplores neurodegenerative, infectious, autoimmune, and traumatic disorders, emphasizing advances in diagnostics, biomarkers, and therapeutic interventions. Researchers and clinicians will discuss novel treatment strategies, risk factor management, and approaches to enhance patient care and functional recovery across acute and chronic neurological conditions.

Sub-tracks:

• Neurodegenerative Disorders

• Neuroinfectious Diseases

• Autoimmune Neurological Disorders

• Traumatic Nervous System Injuries

• Diagnostic Innovations

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 8: Neuro-oncology

Neuro-oncology focuses on tumors of the central and peripheral nervous system, including brain and spinal cord malignancies. This Sessionhighlights advances in diagnosis, imaging, surgical techniques, immunotherapy, and precision medicine approaches. Emphasis is placed on multidisciplinary care, patient quality of life, and emerging clinical trials aiming to improve survival and functional outcomes for patients with neurological cancers.

Sub-tracks:

• Brain Tumors

• Spinal Cord Tumors

• Pediatric Neuro-oncology

• Surgical and Radiation Advances

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 9: Neurosurgery

Neurosurgery involves surgical interventions on the nervous system to treat trauma, tumors, vascular disorders, and degenerative diseases. This Sessionhighlights innovations in minimally invasive surgery, robotics, neuro-navigation, and post-operative care. Emphasis is on precision techniques, patient safety, and outcomes, as well as integration with neuro-imaging and multidisciplinary approaches to enhance surgical efficiency and improve recovery in complex neurological conditions.

Sub-tracks:

• Minimally Invasive Neurosurgery

• Spinal Surgery

• Brain Tumor Surgery

• Pediatric Neurosurgery

• Surgical Innovation and Robotics

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 10: Alzheimer’s & Parkinson’s

This Sessionfocuses on neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases, affecting cognition, movement, and daily living. Topics include pathophysiology, biomarkers, early diagnosis, disease-modifying therapies, and patient-centered care. Research on innovative drug development, gene therapy, and neurorehabilitation strategies is emphasized to slow progression, improve quality of life, and support caregivers in managing chronic neurodegenerative conditions.

Sub-tracks:

• Alzheimer’s Disease Mechanisms and Therapies

• Parkinson’s Disease and Movement Disorders

• Biomarkers and Diagnostics

• Neurorehabilitation Approaches

• Drug Discovery and Clinical Trials

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 11: Neurotrauma

Neurotrauma focuses on injuries to the brain, spinal cord, and peripheral nerves caused by accidents, falls, or violence. This Sessionexplores acute management, neurocritical care, surgical interventions, and rehabilitation strategies. Emphasis is placed on improving survival, functional recovery, and quality of life through advancements in imaging, neuro-monitoring, and innovative therapeutic approaches that reduce long-term neurological deficits.

Sub-tracks:

• Traumatic Brain Injury Management

• Spinal Cord Injury Care

• Neurocritical Care

• Rehabilitation Post-Neurotrauma

• Neuroprotective Strategies

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 12: Neuropharmacology & Therapeutics

Neuropharmacology studies the effects of drugs on the nervous system, aiming to develop treatments for neurological and psychiatric disorders. This Sessionemphasizes drug discovery, mechanisms of action, clinical trials, and personalized therapies. Topics include innovative pharmacological interventions, neuroprotective agents, and neuromodulation strategies, fostering collaboration between researchers, clinicians, and industry to enhance patient outcomes and advance therapeutic innovation.

Sub-tracks:

• Neuroprotective Drug Development

• Neuropsychiatric Therapeutics

• Pharmacokinetics and Drug Delivery

• Neuromodulation Therapies

• Translational Neuropharmacology

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 13: Pain Neurology & Headache Disorders

Pain Neurology and Headache Disorders focus on understanding, diagnosing, and managing chronic and acute neurological pain conditions, including migraines, cluster headaches, and neuropathic pain. This Sessionexplores pathophysiology, pharmacological and non-pharmacological therapies, neuromodulation, and patient-centered care approaches. Advances in precision medicine and emerging treatments aim to improve patient quality of life and reduce the burden of neurological pain globally.

Sub-tracks:

• Migraine and Headache Management

• Neuropathic Pain Therapies

• Pain Mechanisms and Neurobiology

• Neuromodulation Techniques

• Clinical Pain Trials

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 14: Epilepsy & Seizure Disorders

Epilepsy and Seizure Disorders involve abnormal electrical activity in the brain leading to recurrent seizures. This Sessionexplores pathophysiology, genetics, diagnostic innovations, and advanced therapeutic approaches, including anti-epileptic drugs, surgical interventions, and neuromodulation. Emphasis is placed on improving seizure control, patient safety, and quality of life while highlighting advances in personalized treatment strategies and global epilepsy research.

Sub-tracks:

• Genetic and Molecular Epilepsy

• Surgical and Non-surgical Therapies

• Pediatric Epilepsy

• Seizure Monitoring and Diagnostics

• Emerging Anti-Epileptic Drugs

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 15: Stroke & Cerebrovascular Disorders

Stroke and Cerebrovascular Disorders focus on conditions affecting blood flow to the brain, including ischemic and hemorrhagic stroke. This Sessioncovers prevention, acute management, thrombolytic therapies, neurointervention, and rehabilitation. Advancements in imaging, biomarkers, and personalized care strategies are highlighted to improve survival rates, reduce neurological deficits, and enhance recovery, emphasizing multidisciplinary collaboration for optimal patient outcomes.

Sub-tracks:

• Ischemic and Hemorrhagic Stroke

• Acute Stroke Management

• Neurointerventional Therapies

• Stroke Rehabilitation

• Prevention and Risk Management

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 16: Neurogenetics & Rare Disorders

Neurogenetics investigates the genetic basis of neurological conditions, including rare and inherited disorders. This Sessionemphasizes advances in genetic diagnostics, molecular therapies, and personalized medicine. Topics include gene editing, rare disease registries, and novel therapeutic approaches. Understanding the genetic mechanisms of neurological disorders enables early detection, precision interventions, and improved patient outcomes across both pediatric and adult populations.

Sub-tracks:

• Inherited Neurological Disorders

• Genetic Testing and Counseling

• Rare Neurodegenerative Diseases

• Gene Therapy Approaches

• Pediatric Neurogenetics

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 17: Neurotherapeutics & Drug Innovation

This session focuses on the development of novel therapies for neurological disorders, spanning pharmacological, biologic, and advanced molecular treatments. It highlights translational research, drug discovery, clinical trials, and regulatory advances. Innovative therapeutic strategies aim to address neurodegeneration, neuroinflammation, and neuropsychiatric conditions, ultimately enhancing patient care and promoting precision medicine in neurology.

Sub-tracks:

• Novel Drug Development

• Biologic and Molecular Therapies

• Clinical Trials in Neurology

• Translational Neurotherapeutics

• Personalized Medicine Approaches

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 18: Neuroimmunology & Autoimmune Neurology

Neuroimmunology studies the interaction between the nervous and immune systems, focusing on autoimmune and inflammatory neurological disorders. This Sessionexplores multiple sclerosis, autoimmune encephalitis, and neuroinflammatory conditions, highlighting immune mechanisms, diagnostics, and immunotherapy innovations. Collaborative research and clinical trials aim to optimize treatment strategies, improve patient outcomes, and reduce the burden of immune-mediated neurological diseases.

Sub-tracks:

• Multiple Sclerosis and Related Disorders

• Autoimmune Encephalitis

• Neuroinflammation Mechanisms

• Immunotherapies in Neurology

• Translational Neuroimmunology

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 19: Cognitive & Behavioral Neurology

Cognitive & Behavioral Neurology focuses on neurological disorders affecting cognition, memory, language, and behavior. This Sessionhighlights clinical evaluation, neuroimaging, neuropsychology, and therapeutic interventions for conditions such as dementia, traumatic brain injury, and psychiatric-neurological overlap syndromes. Research on cognitive rehabilitation, biomarkers, and innovative therapies aims to enhance patient outcomes and quality of life.

Sub-tracks:

• Dementia and Memory Disorders

• Cognitive Rehabilitation

• Behavioral Neurology

• Neuropsychological Assessment

• Innovative Therapies for Cognitive Disorders

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 20: Artificial Intelligence & Digital Neurology

Artificial Intelligence & Digital Neurology explores the integration of AI, machine learning, and digital technologies in neurological research, diagnostics, and patient care. This Session covers predictive modeling, neuroimaging analysis, remote monitoring, and digital therapeutics. Innovations in AI-driven tools enhance early diagnosis, personalized treatment planning, and data-driven decision-making in clinical neurology, improving outcomes and efficiency.

Sub-tracks:

• AI in Neuroimaging

• Digital Health Technologies

• Predictive Models in Neurology

• Tele-neurology & Remote Monitoring

• Machine Learning for Drug Discovery

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Session 21: Case Studies

Case Studies provide practical insights into unique, rare, or complex neurological cases, bridging clinical experience with research. This Sessionencourages the presentation and discussion of diagnostic challenges, innovative interventions, and multidisciplinary management strategies. Sharing real-world experiences enhances learning, informs clinical decision-making, and fosters collaboration across global neurology communities.

Sub-tracks:

• Rare Neurological Case Reports

• Diagnostic Challenges

• Innovative Therapeutic Approaches

• Multidisciplinary Case Management

• Clinical Lessons and Insights

Associated Societies:

World Federation of Neurology | European Academy of Neurology | American Academy of Neurology | International Brain Research Organization | International Society for Neurochemistry | Neurological Society of Prague | World Stroke Organization | Prague Neurology Society

Associated Journals & Conferences:

Neurology 2026 | Journal of Neurology, Neurosurgery & Psychiatry | Journal of Clinical Neuroscience | Neurotherapeutics | Frontiers in Neurology | International Neurology Conference 2026 | Global Neuroscience Summit 2026 | Clinical Neurology Conference 2026

Market Analysis

Market Size & Growth — Global Overview

• The global neurology drugs market was valued at ≈ USD 82.5 billion in 2024. It is projected to grow to around USD 134.1 billion by 2032, at a CAGR ~ 6.3%.
• Another estimate puts the neurology-therapeutics market (broader neurology market) at USD 63.0 billion in 2023, with forecast to reach ≈ USD 94.8 billion by 2029 — a CAGR of ~ 7.1%.
• For neurodegenerative disease drugs (subset focusing on e.g. Alzheimer’s, Parkinson’s, etc.), the market was estimated at USD 43.7 billion in 2024, rising to ≈ USD 64.9 billion by 2030 (CAGR ~ 6.8%).
• The broader neuroscience market (which includes diagnostics, devices, instruments, imaging etc.) was estimated at USD 38.9 billion in 2025, with forecast ≈ USD 52.5 billion by 2030, CAGR ~ 6.2%.

Sub-Segments & Therapeutic Channels — What’s Growing

The “neurology & therapeutics” ecosystem is not just about classic drugs — several sub-segments are growing rapidly:

• Digital Therapeutics (DTx) for Neurology — use of software, apps, wearables to manage neurological disorders. Market size was ~ USD 245.4 million in 2024 and expected to reach ≈ USD 496.4 million by 2034 (CAGR ~ 8.2%).  
• Clinical Trials for Neurology 2026 — the segment that supports development of new therapies. As of 2025, estimated at USD 6.8 billion, with projections up to USD 12.5 billion by 2035 (CAGR ~ 6.3%).
• Within disease categories: neurodegenerative diseases (e.g. Alzheimer’s, Parkinson’s), neurovascular disorders, epilepsy, multiple sclerosis — these represent large and growing shares of demand.

Key Market Drivers & Trends

Why is the neurology therapeutics market growing — and what’s shaping its future:

• Rising prevalence of neurological disorders: Aging populations globally lead to more neuro-degenerative conditions (Alzheimer’s, Parkinson’s), stroke, epilepsy, etc.
• Advances in diagnostics & neuro-science research: better imaging, biomarkers, genetics, enabling early detection and personalized medicine.
• Growth in digital health & remote care: digital therapeutics, wearables, remote monitoring enable non-invasive, accessible, scalable care — especially relevant for chronic neurological diseases.
• Investment in R&D and clinical trials: greater focus on finding disease-modifying therapies, rather than just symptom management. Clinical trials market growth reflects that.
• Global healthcare infrastructure expansion & unmet need in emerging markets: As more regions improve access to neurological care, demand rises — especially in regions like Asia-Pacific expected to grow fastest.